Pettee Investors, Inc. Merck & Co., Inc. Transaction History

Pettee Investors, Inc.

$229 Million
Q1 2024

A detailed history of Pettee Investors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pettee Investors, Inc. holds 30,514 shares of MRK stock, worth $3.9 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares

30,514

Previous 32,958 7.42%

Holding current value

$3.9 Million

Previous $3.59 Million 12.05%

% of portfolio

1.76%

Previous 1.63%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$113.24 - $131.95 $276,758 - $322,485	-2,444 Reduced 7.42%	30,514 $4.03 Million
Q3 2023 Oct 20, 2023	SELL	$102.95 - $114.33 $226,490 - $251,526	-2,200 Reduced 6.26%	32,958 $3.39 Million
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $65,426 - $73,499	-774 Reduced 2.15%	35,158 $3.03 Million
Q2 2022 Jul 25, 2022	SELL	$83.49 - $94.64 $18,284 - $20,726	-219 Reduced 0.61%	35,932 $3.28 Million
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $34,592 - $38,262	-492 Reduced 1.34%	36,151 $2.81 Million

Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $3,588 - $3,982	-50 Reduced 0.14%	36,643 $3 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $11,637 - $13,131	-150 Reduced 0.41%	36,693 $3.34 Million
Q3 2019 Oct 30, 2019	SELL	$76.08 - $82.93 $6,390 - $6,966	-84 Reduced 0.23%	36,843 $3.1 Million
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $41,065 - $47,974	-588 Reduced 1.57%	36,927 $3.1 Million
Q4 2018 Feb 06, 2019	SELL	$65.24 - $75.71 $35,490 - $41,186	-544 Reduced 1.43%	37,515 $2.87 Million
Q3 2017 Nov 02, 2017	BUY	$58.67 - $63.13 $2.23 Million - $2.4 Million	38,059	38,059 $2.44 Million

Others Institutions Holding MRK

# of Institutions

3,775

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $324B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettee Investors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pettee Investors, Inc. with notifications on news.

Account

Pettee Investors, Inc. Merck & Co., Inc. Transaction History